Observational studyEuropean journal of cancer (Oxford, England : 1990)2021

Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment.

Tania Buttiron Webber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.